ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	29 July 2022
Main ID:	NCT03022461
Date of registration:	12/01/2017
Prospective Registration:	No
Primary sponsor:	Abbott Medical Devices
Public title:	HeartMate 3 CE Mark Study Long Term Follow-up HM3 CE LTFU
Scientific title:	HeartMate 3 CE Mark Study Long Term Follow-up Clinical Investigation Plan
Date of first enrolment:	June 23, 2014
Target sample size:	25
Recruitment status:	Completed
URL:	https://clinicaltrials.gov/show/NCT03022461
Study type:	Observational
Study design:
Phase:

Countries of recruitment
Australia	Austria	Canada	Czech Republic	Czechia	Germany	Kazakhstan

Contacts

Name:	Carlo Gazzola, B. Sc.
Address:
Telephone:
Email:
Affiliation:	Abbott

Key inclusion & exclusion criteria

Health Condition(s) or Problem(s) studied

Intervention(s)

Primary Outcome(s)

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

Secondary Sponsor(s)

Ethics review

Results

Results available:	Yes
Date Posted:	02/12/2021
Date Completed:
URL:	https://clinicaltrials.gov/ct2/show/results/NCT03022461

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.